nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—Niclosamide—STAT3—melanoma	0.0301	0.725	CrCbGaD
Tolcapone—Tolmetin—CXCL8—melanoma	0.00883	0.213	CrCbGaD
Tolcapone—COMT—Dopamine metabolism—TYR—melanoma	0.00418	0.356	CbGpPWpGaD
Tolcapone—Tolmetin—PTGS2—melanoma	0.00258	0.0621	CrCbGaD
Tolcapone—Hallucination—Carmustine—melanoma	0.0021	0.00222	CcSEcCtD
Tolcapone—Hypersensitivity—Vemurafenib—melanoma	0.00209	0.00221	CcSEcCtD
Tolcapone—Oedema peripheral—Carmustine—melanoma	0.00208	0.0022	CcSEcCtD
Tolcapone—Atrial fibrillation—Docetaxel—melanoma	0.00207	0.00219	CcSEcCtD
Tolcapone—Haemoglobin—Temozolomide—melanoma	0.00205	0.00217	CcSEcCtD
Tolcapone—Haemorrhage—Temozolomide—melanoma	0.00204	0.00216	CcSEcCtD
Tolcapone—Asthenia—Vemurafenib—melanoma	0.00204	0.00215	CcSEcCtD
Tolcapone—Hypoaesthesia—Temozolomide—melanoma	0.00203	0.00215	CcSEcCtD
Tolcapone—Hallucination—Temozolomide—melanoma	0.00203	0.00215	CcSEcCtD
Tolcapone—Pharyngitis—Temozolomide—melanoma	0.00203	0.00214	CcSEcCtD
Tolcapone—Chills—Dactinomycin—melanoma	0.00203	0.00214	CcSEcCtD
Tolcapone—Urinary tract disorder—Temozolomide—melanoma	0.00202	0.00213	CcSEcCtD
Tolcapone—Oedema peripheral—Temozolomide—melanoma	0.00201	0.00213	CcSEcCtD
Tolcapone—Cardiac failure—Docetaxel—melanoma	0.00201	0.00213	CcSEcCtD
Tolcapone—Pruritus—Vemurafenib—melanoma	0.00201	0.00212	CcSEcCtD
Tolcapone—Lethargy—Docetaxel—melanoma	0.002	0.00212	CcSEcCtD
Tolcapone—Urethral disorder—Temozolomide—melanoma	0.002	0.00212	CcSEcCtD
Tolcapone—Alopecia—Dactinomycin—melanoma	0.002	0.00211	CcSEcCtD
Tolcapone—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00196	0.00207	CcSEcCtD
Tolcapone—Ill-defined disorder—Bleomycin—melanoma	0.00196	0.00207	CcSEcCtD
Tolcapone—Anaemia—Bleomycin—melanoma	0.00195	0.00206	CcSEcCtD
Tolcapone—Diarrhoea—Vemurafenib—melanoma	0.00194	0.00205	CcSEcCtD
Tolcapone—Migraine—Docetaxel—melanoma	0.00193	0.00204	CcSEcCtD
Tolcapone—Erythema multiforme—Temozolomide—melanoma	0.00193	0.00204	CcSEcCtD
Tolcapone—Tinnitus—Temozolomide—melanoma	0.0019	0.00201	CcSEcCtD
Tolcapone—Malaise—Bleomycin—melanoma	0.0019	0.00201	CcSEcCtD
Tolcapone—Arrhythmia—Carmustine—melanoma	0.00189	0.00199	CcSEcCtD
Tolcapone—Dizziness—Vemurafenib—melanoma	0.00188	0.00198	CcSEcCtD
Tolcapone—Alopecia—Carmustine—melanoma	0.00187	0.00197	CcSEcCtD
Tolcapone—Angiopathy—Temozolomide—melanoma	0.00185	0.00196	CcSEcCtD
Tolcapone—Mental disorder—Carmustine—melanoma	0.00185	0.00196	CcSEcCtD
Tolcapone—Mediastinal disorder—Temozolomide—melanoma	0.00184	0.00194	CcSEcCtD
Tolcapone—Cough—Bleomycin—melanoma	0.00184	0.00194	CcSEcCtD
Tolcapone—Chills—Temozolomide—melanoma	0.00183	0.00194	CcSEcCtD
Tolcapone—Dehydration—Docetaxel—melanoma	0.00183	0.00193	CcSEcCtD
Tolcapone—Ill-defined disorder—Dactinomycin—melanoma	0.00182	0.00193	CcSEcCtD
Tolcapone—Anaemia—Dactinomycin—melanoma	0.00182	0.00192	CcSEcCtD
Tolcapone—Vomiting—Vemurafenib—melanoma	0.00181	0.00191	CcSEcCtD
Tolcapone—Alopecia—Temozolomide—melanoma	0.00181	0.00191	CcSEcCtD
Tolcapone—Myalgia—Bleomycin—melanoma	0.00179	0.0019	CcSEcCtD
Tolcapone—Chest pain—Bleomycin—melanoma	0.00179	0.0019	CcSEcCtD
Tolcapone—Rash—Vemurafenib—melanoma	0.00179	0.00189	CcSEcCtD
Tolcapone—Mental disorder—Temozolomide—melanoma	0.00179	0.00189	CcSEcCtD
Tolcapone—Dermatitis—Vemurafenib—melanoma	0.00179	0.00189	CcSEcCtD
Tolcapone—Headache—Vemurafenib—melanoma	0.00178	0.00188	CcSEcCtD
Tolcapone—Discomfort—Bleomycin—melanoma	0.00177	0.00187	CcSEcCtD
Tolcapone—Malaise—Dactinomycin—melanoma	0.00177	0.00187	CcSEcCtD
Tolcapone—Cramp muscle—Docetaxel—melanoma	0.00177	0.00187	CcSEcCtD
Tolcapone—Dysgeusia—Temozolomide—melanoma	0.00174	0.00184	CcSEcCtD
Tolcapone—Confusional state—Bleomycin—melanoma	0.00173	0.00183	CcSEcCtD
Tolcapone—Vision blurred—Carmustine—melanoma	0.00173	0.00183	CcSEcCtD
Tolcapone—Alanine aminotransferase increased—Docetaxel—melanoma	0.00173	0.00183	CcSEcCtD
Tolcapone—Tremor—Carmustine—melanoma	0.00172	0.00182	CcSEcCtD
Tolcapone—Oedema—Bleomycin—melanoma	0.00172	0.00182	CcSEcCtD
Tolcapone—Infection—Bleomycin—melanoma	0.00171	0.00181	CcSEcCtD
Tolcapone—Anaemia—Carmustine—melanoma	0.0017	0.0018	CcSEcCtD
Tolcapone—Dysphagia—Docetaxel—melanoma	0.0017	0.00179	CcSEcCtD
Tolcapone—Agitation—Carmustine—melanoma	0.00169	0.00179	CcSEcCtD
Tolcapone—Nausea—Vemurafenib—melanoma	0.00169	0.00178	CcSEcCtD
Tolcapone—Thrombocytopenia—Bleomycin—melanoma	0.00168	0.00178	CcSEcCtD
Tolcapone—Vision blurred—Temozolomide—melanoma	0.00168	0.00177	CcSEcCtD
Tolcapone—Myalgia—Dactinomycin—melanoma	0.00167	0.00177	CcSEcCtD
Tolcapone—Tremor—Temozolomide—melanoma	0.00167	0.00176	CcSEcCtD
Tolcapone—Discomfort—Dactinomycin—melanoma	0.00165	0.00175	CcSEcCtD
Tolcapone—Angina pectoris—Docetaxel—melanoma	0.00165	0.00175	CcSEcCtD
Tolcapone—Ill-defined disorder—Temozolomide—melanoma	0.00165	0.00174	CcSEcCtD
Tolcapone—Anaemia—Temozolomide—melanoma	0.00164	0.00174	CcSEcCtD
Tolcapone—Anorexia—Bleomycin—melanoma	0.00164	0.00173	CcSEcCtD
Tolcapone—Agitation—Temozolomide—melanoma	0.00163	0.00173	CcSEcCtD
Tolcapone—Hypotension—Bleomycin—melanoma	0.00161	0.0017	CcSEcCtD
Tolcapone—Oedema—Dactinomycin—melanoma	0.0016	0.00169	CcSEcCtD
Tolcapone—Malaise—Temozolomide—melanoma	0.0016	0.00169	CcSEcCtD
Tolcapone—Vertigo—Temozolomide—melanoma	0.0016	0.00169	CcSEcCtD
Tolcapone—Infection—Dactinomycin—melanoma	0.00159	0.00168	CcSEcCtD
Tolcapone—Hypertension—Carmustine—melanoma	0.00159	0.00168	CcSEcCtD
Tolcapone—Palpitations—Temozolomide—melanoma	0.00157	0.00166	CcSEcCtD
Tolcapone—Thrombocytopenia—Dactinomycin—melanoma	0.00157	0.00166	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Bleomycin—melanoma	0.00157	0.00166	CcSEcCtD
Tolcapone—Chest pain—Carmustine—melanoma	0.00157	0.00165	CcSEcCtD
Tolcapone—Myalgia—Carmustine—melanoma	0.00157	0.00165	CcSEcCtD
Tolcapone—Anxiety—Carmustine—melanoma	0.00156	0.00165	CcSEcCtD
Tolcapone—Cough—Temozolomide—melanoma	0.00155	0.00164	CcSEcCtD
Tolcapone—Paraesthesia—Bleomycin—melanoma	0.00154	0.00163	CcSEcCtD
Tolcapone—Weight decreased—Docetaxel—melanoma	0.00154	0.00162	CcSEcCtD
Tolcapone—Hypertension—Temozolomide—melanoma	0.00154	0.00162	CcSEcCtD
Tolcapone—Dyspnoea—Bleomycin—melanoma	0.00153	0.00162	CcSEcCtD
Tolcapone—Anorexia—Dactinomycin—melanoma	0.00153	0.00162	CcSEcCtD
Tolcapone—Pneumonia—Docetaxel—melanoma	0.00152	0.00161	CcSEcCtD
Tolcapone—Confusional state—Carmustine—melanoma	0.00151	0.0016	CcSEcCtD
Tolcapone—Arthralgia—Temozolomide—melanoma	0.00151	0.0016	CcSEcCtD
Tolcapone—Myalgia—Temozolomide—melanoma	0.00151	0.0016	CcSEcCtD
Tolcapone—Infestation—Docetaxel—melanoma	0.00151	0.0016	CcSEcCtD
Tolcapone—Infestation NOS—Docetaxel—melanoma	0.00151	0.0016	CcSEcCtD
Tolcapone—Anxiety—Temozolomide—melanoma	0.00151	0.00159	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.0015	0.00159	CcSEcCtD
Tolcapone—Oedema—Carmustine—melanoma	0.0015	0.00159	CcSEcCtD
Tolcapone—Discomfort—Temozolomide—melanoma	0.0015	0.00158	CcSEcCtD
Tolcapone—Decreased appetite—Bleomycin—melanoma	0.0015	0.00158	CcSEcCtD
Tolcapone—Infection—Carmustine—melanoma	0.00149	0.00158	CcSEcCtD
Tolcapone—Acute coronary syndrome—Docetaxel—melanoma	0.00149	0.00158	CcSEcCtD
Tolcapone—Myocardial infarction—Docetaxel—melanoma	0.00148	0.00157	CcSEcCtD
Tolcapone—Neuropathy peripheral—Docetaxel—melanoma	0.00148	0.00157	CcSEcCtD
Tolcapone—Dry mouth—Temozolomide—melanoma	0.00148	0.00156	CcSEcCtD
Tolcapone—Stomatitis—Docetaxel—melanoma	0.00148	0.00156	CcSEcCtD
Tolcapone—Pain—Bleomycin—melanoma	0.00147	0.00155	CcSEcCtD
Tolcapone—Thrombocytopenia—Carmustine—melanoma	0.00147	0.00155	CcSEcCtD
Tolcapone—Tachycardia—Carmustine—melanoma	0.00147	0.00155	CcSEcCtD
Tolcapone—Confusional state—Temozolomide—melanoma	0.00146	0.00155	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00146	0.00154	CcSEcCtD
Tolcapone—Oedema—Temozolomide—melanoma	0.00145	0.00153	CcSEcCtD
Tolcapone—Infection—Temozolomide—melanoma	0.00144	0.00152	CcSEcCtD
Tolcapone—Anorexia—Carmustine—melanoma	0.00143	0.00151	CcSEcCtD
Tolcapone—Epistaxis—Docetaxel—melanoma	0.00143	0.00151	CcSEcCtD
Tolcapone—Nervous system disorder—Temozolomide—melanoma	0.00142	0.0015	CcSEcCtD
Tolcapone—Thrombocytopenia—Temozolomide—melanoma	0.00142	0.0015	CcSEcCtD
Tolcapone—Feeling abnormal—Bleomycin—melanoma	0.00142	0.0015	CcSEcCtD
Tolcapone—Skin disorder—Temozolomide—melanoma	0.00141	0.00149	CcSEcCtD
Tolcapone—Hypotension—Carmustine—melanoma	0.0014	0.00148	CcSEcCtD
Tolcapone—Hyperhidrosis—Temozolomide—melanoma	0.0014	0.00148	CcSEcCtD
Tolcapone—Decreased appetite—Dactinomycin—melanoma	0.00139	0.00147	CcSEcCtD
Tolcapone—Fatigue—Dactinomycin—melanoma	0.00138	0.00146	CcSEcCtD
Tolcapone—Anorexia—Temozolomide—melanoma	0.00138	0.00146	CcSEcCtD
Tolcapone—Pain—Dactinomycin—melanoma	0.00137	0.00145	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Carmustine—melanoma	0.00137	0.00145	CcSEcCtD
Tolcapone—Urticaria—Bleomycin—melanoma	0.00137	0.00144	CcSEcCtD
Tolcapone—Haemoglobin—Docetaxel—melanoma	0.00137	0.00144	CcSEcCtD
Tolcapone—Rhinitis—Docetaxel—melanoma	0.00136	0.00144	CcSEcCtD
Tolcapone—Body temperature increased—Bleomycin—melanoma	0.00136	0.00144	CcSEcCtD
Tolcapone—Haemorrhage—Docetaxel—melanoma	0.00136	0.00143	CcSEcCtD
Tolcapone—Hypoaesthesia—Docetaxel—melanoma	0.00135	0.00143	CcSEcCtD
Tolcapone—Paraesthesia—Carmustine—melanoma	0.00135	0.00142	CcSEcCtD
Tolcapone—Pharyngitis—Docetaxel—melanoma	0.00135	0.00142	CcSEcCtD
Tolcapone—Urinary tract disorder—Docetaxel—melanoma	0.00134	0.00142	CcSEcCtD
Tolcapone—Dyspnoea—Carmustine—melanoma	0.00134	0.00141	CcSEcCtD
Tolcapone—Oedema peripheral—Docetaxel—melanoma	0.00134	0.00141	CcSEcCtD
Tolcapone—Somnolence—Carmustine—melanoma	0.00134	0.00141	CcSEcCtD
Tolcapone—Urethral disorder—Docetaxel—melanoma	0.00133	0.00141	CcSEcCtD
Tolcapone—Feeling abnormal—Dactinomycin—melanoma	0.00132	0.0014	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Temozolomide—melanoma	0.00132	0.0014	CcSEcCtD
Tolcapone—Gastrointestinal pain—Dactinomycin—melanoma	0.00131	0.00139	CcSEcCtD
Tolcapone—Decreased appetite—Carmustine—melanoma	0.00131	0.00138	CcSEcCtD
Tolcapone—Paraesthesia—Temozolomide—melanoma	0.0013	0.00138	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Carmustine—melanoma	0.0013	0.00137	CcSEcCtD
Tolcapone—Dyspnoea—Temozolomide—melanoma	0.00129	0.00137	CcSEcCtD
Tolcapone—Somnolence—Temozolomide—melanoma	0.00129	0.00136	CcSEcCtD
Tolcapone—Erythema multiforme—Docetaxel—melanoma	0.00128	0.00136	CcSEcCtD
Tolcapone—Constipation—Carmustine—melanoma	0.00128	0.00136	CcSEcCtD
Tolcapone—Pain—Carmustine—melanoma	0.00128	0.00136	CcSEcCtD
Tolcapone—Dyspepsia—Temozolomide—melanoma	0.00128	0.00135	CcSEcCtD
Tolcapone—Abdominal pain—Dactinomycin—melanoma	0.00127	0.00134	CcSEcCtD
Tolcapone—Body temperature increased—Dactinomycin—melanoma	0.00127	0.00134	CcSEcCtD
Tolcapone—Hypersensitivity—Bleomycin—melanoma	0.00127	0.00134	CcSEcCtD
Tolcapone—Decreased appetite—Temozolomide—melanoma	0.00126	0.00133	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Temozolomide—melanoma	0.00125	0.00132	CcSEcCtD
Tolcapone—Fatigue—Temozolomide—melanoma	0.00125	0.00132	CcSEcCtD
Tolcapone—Pain—Temozolomide—melanoma	0.00124	0.00131	CcSEcCtD
Tolcapone—Constipation—Temozolomide—melanoma	0.00124	0.00131	CcSEcCtD
Tolcapone—Feeling abnormal—Carmustine—melanoma	0.00124	0.00131	CcSEcCtD
Tolcapone—Asthenia—Bleomycin—melanoma	0.00123	0.0013	CcSEcCtD
Tolcapone—Angiopathy—Docetaxel—melanoma	0.00123	0.0013	CcSEcCtD
Tolcapone—Gastrointestinal pain—Carmustine—melanoma	0.00123	0.0013	CcSEcCtD
Tolcapone—Mediastinal disorder—Docetaxel—melanoma	0.00122	0.00129	CcSEcCtD
Tolcapone—Chills—Docetaxel—melanoma	0.00122	0.00129	CcSEcCtD
Tolcapone—Pruritus—Bleomycin—melanoma	0.00122	0.00129	CcSEcCtD
Tolcapone—Arrhythmia—Docetaxel—melanoma	0.00121	0.00128	CcSEcCtD
Tolcapone—Alopecia—Docetaxel—melanoma	0.0012	0.00127	CcSEcCtD
Tolcapone—Feeling abnormal—Temozolomide—melanoma	0.0012	0.00126	CcSEcCtD
Tolcapone—Mental disorder—Docetaxel—melanoma	0.00119	0.00126	CcSEcCtD
Tolcapone—Abdominal pain—Carmustine—melanoma	0.00119	0.00125	CcSEcCtD
Tolcapone—Body temperature increased—Carmustine—melanoma	0.00119	0.00125	CcSEcCtD
Tolcapone—Gastrointestinal pain—Temozolomide—melanoma	0.00119	0.00125	CcSEcCtD
Tolcapone—Hypersensitivity—Dactinomycin—melanoma	0.00118	0.00125	CcSEcCtD
Tolcapone—Dysgeusia—Docetaxel—melanoma	0.00116	0.00122	CcSEcCtD
Tolcapone—Urticaria—Temozolomide—melanoma	0.00115	0.00122	CcSEcCtD
Tolcapone—Asthenia—Dactinomycin—melanoma	0.00115	0.00122	CcSEcCtD
Tolcapone—Body temperature increased—Temozolomide—melanoma	0.00115	0.00121	CcSEcCtD
Tolcapone—Abdominal pain—Temozolomide—melanoma	0.00115	0.00121	CcSEcCtD
Tolcapone—Muscle spasms—Docetaxel—melanoma	0.00114	0.0012	CcSEcCtD
Tolcapone—Hypersensitivity—Carmustine—melanoma	0.00111	0.00117	CcSEcCtD
Tolcapone—Diarrhoea—Dactinomycin—melanoma	0.0011	0.00116	CcSEcCtD
Tolcapone—Vomiting—Bleomycin—melanoma	0.00109	0.00116	CcSEcCtD
Tolcapone—Anaemia—Docetaxel—melanoma	0.00109	0.00115	CcSEcCtD
Tolcapone—Rash—Bleomycin—melanoma	0.00108	0.00115	CcSEcCtD
Tolcapone—Dermatitis—Bleomycin—melanoma	0.00108	0.00114	CcSEcCtD
Tolcapone—Asthenia—Carmustine—melanoma	0.00108	0.00114	CcSEcCtD
Tolcapone—Hypersensitivity—Temozolomide—melanoma	0.00107	0.00113	CcSEcCtD
Tolcapone—Syncope—Docetaxel—melanoma	0.00106	0.00112	CcSEcCtD
Tolcapone—Palpitations—Docetaxel—melanoma	0.00105	0.0011	CcSEcCtD
Tolcapone—Asthenia—Temozolomide—melanoma	0.00104	0.0011	CcSEcCtD
Tolcapone—Loss of consciousness—Docetaxel—melanoma	0.00104	0.0011	CcSEcCtD
Tolcapone—Cough—Docetaxel—melanoma	0.00103	0.00109	CcSEcCtD
Tolcapone—Diarrhoea—Carmustine—melanoma	0.00103	0.00109	CcSEcCtD
Tolcapone—Pruritus—Temozolomide—melanoma	0.00103	0.00108	CcSEcCtD
Tolcapone—Nausea—Bleomycin—melanoma	0.00102	0.00108	CcSEcCtD
Tolcapone—Hypertension—Docetaxel—melanoma	0.00102	0.00108	CcSEcCtD
Tolcapone—Vomiting—Dactinomycin—melanoma	0.00102	0.00108	CcSEcCtD
Tolcapone—Rash—Dactinomycin—melanoma	0.00101	0.00107	CcSEcCtD
Tolcapone—Chest pain—Docetaxel—melanoma	0.00101	0.00106	CcSEcCtD
Tolcapone—Arthralgia—Docetaxel—melanoma	0.00101	0.00106	CcSEcCtD
Tolcapone—Myalgia—Docetaxel—melanoma	0.00101	0.00106	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.001	0.00106	CcSEcCtD
Tolcapone—Dizziness—Carmustine—melanoma	0.000993	0.00105	CcSEcCtD
Tolcapone—Diarrhoea—Temozolomide—melanoma	0.000993	0.00105	CcSEcCtD
Tolcapone—Dry mouth—Docetaxel—melanoma	0.000985	0.00104	CcSEcCtD
Tolcapone—Confusional state—Docetaxel—melanoma	0.000973	0.00103	CcSEcCtD
Tolcapone—Oedema—Docetaxel—melanoma	0.000965	0.00102	CcSEcCtD
Tolcapone—Dizziness—Temozolomide—melanoma	0.00096	0.00101	CcSEcCtD
Tolcapone—Infection—Docetaxel—melanoma	0.000959	0.00101	CcSEcCtD
Tolcapone—Vomiting—Carmustine—melanoma	0.000955	0.00101	CcSEcCtD
Tolcapone—Nausea—Dactinomycin—melanoma	0.000953	0.00101	CcSEcCtD
Tolcapone—Shock—Docetaxel—melanoma	0.00095	0.001	CcSEcCtD
Tolcapone—Rash—Carmustine—melanoma	0.000947	0.001	CcSEcCtD
Tolcapone—Nervous system disorder—Docetaxel—melanoma	0.000946	0.001	CcSEcCtD
Tolcapone—Dermatitis—Carmustine—melanoma	0.000946	0.000999	CcSEcCtD
Tolcapone—Thrombocytopenia—Docetaxel—melanoma	0.000945	0.000998	CcSEcCtD
Tolcapone—Tachycardia—Docetaxel—melanoma	0.000942	0.000995	CcSEcCtD
Tolcapone—Headache—Carmustine—melanoma	0.000941	0.000994	CcSEcCtD
Tolcapone—Skin disorder—Docetaxel—melanoma	0.000937	0.00099	CcSEcCtD
Tolcapone—Vomiting—Temozolomide—melanoma	0.000923	0.000975	CcSEcCtD
Tolcapone—Anorexia—Docetaxel—melanoma	0.00092	0.000972	CcSEcCtD
Tolcapone—Rash—Temozolomide—melanoma	0.000915	0.000967	CcSEcCtD
Tolcapone—Dermatitis—Temozolomide—melanoma	0.000914	0.000966	CcSEcCtD
Tolcapone—Headache—Temozolomide—melanoma	0.000909	0.00096	CcSEcCtD
Tolcapone—Hypotension—Docetaxel—melanoma	0.000902	0.000953	CcSEcCtD
Tolcapone—Nausea—Carmustine—melanoma	0.000892	0.000942	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Docetaxel—melanoma	0.000879	0.000929	CcSEcCtD
Tolcapone—Paraesthesia—Docetaxel—melanoma	0.000867	0.000915	CcSEcCtD
Tolcapone—Nausea—Temozolomide—melanoma	0.000862	0.000911	CcSEcCtD
Tolcapone—Dyspnoea—Docetaxel—melanoma	0.00086	0.000909	CcSEcCtD
Tolcapone—Somnolence—Docetaxel—melanoma	0.000858	0.000906	CcSEcCtD
Tolcapone—Dyspepsia—Docetaxel—melanoma	0.00085	0.000897	CcSEcCtD
Tolcapone—Decreased appetite—Docetaxel—melanoma	0.000839	0.000886	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Docetaxel—melanoma	0.000833	0.00088	CcSEcCtD
Tolcapone—Fatigue—Docetaxel—melanoma	0.000832	0.000879	CcSEcCtD
Tolcapone—Pain—Docetaxel—melanoma	0.000825	0.000872	CcSEcCtD
Tolcapone—Constipation—Docetaxel—melanoma	0.000825	0.000872	CcSEcCtD
Tolcapone—Feeling abnormal—Docetaxel—melanoma	0.000795	0.00084	CcSEcCtD
Tolcapone—Gastrointestinal pain—Docetaxel—melanoma	0.000789	0.000834	CcSEcCtD
Tolcapone—Abdominal pain—Docetaxel—melanoma	0.000763	0.000806	CcSEcCtD
Tolcapone—Body temperature increased—Docetaxel—melanoma	0.000763	0.000806	CcSEcCtD
Tolcapone—COMT—Phase II conjugation—UGT2B10—melanoma	0.000738	0.0629	CbGpPWpGaD
Tolcapone—COMT—Estrogen metabolism—CYP1B1—melanoma	0.000737	0.0628	CbGpPWpGaD
Tolcapone—Hypersensitivity—Docetaxel—melanoma	0.000711	0.000751	CcSEcCtD
Tolcapone—Asthenia—Docetaxel—melanoma	0.000692	0.000731	CcSEcCtD
Tolcapone—Pruritus—Docetaxel—melanoma	0.000683	0.000721	CcSEcCtD
Tolcapone—Diarrhoea—Docetaxel—melanoma	0.00066	0.000698	CcSEcCtD
Tolcapone—Dizziness—Docetaxel—melanoma	0.000638	0.000674	CcSEcCtD
Tolcapone—Vomiting—Docetaxel—melanoma	0.000614	0.000648	CcSEcCtD
Tolcapone—Rash—Docetaxel—melanoma	0.000609	0.000643	CcSEcCtD
Tolcapone—Dermatitis—Docetaxel—melanoma	0.000608	0.000642	CcSEcCtD
Tolcapone—Headache—Docetaxel—melanoma	0.000605	0.000639	CcSEcCtD
Tolcapone—Nausea—Docetaxel—melanoma	0.000573	0.000606	CcSEcCtD
Tolcapone—COMT—Biological oxidations—UGT2B10—melanoma	0.000432	0.0368	CbGpPWpGaD
Tolcapone—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—melanoma	0.000362	0.0308	CbGpPWpGaD
Tolcapone—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—melanoma	0.00033	0.028	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—AKR1B10—melanoma	0.000275	0.0234	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—SLC6A11—melanoma	0.000254	0.0216	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—SLC6A11—melanoma	0.000194	0.0165	CbGpPWpGaD
Tolcapone—CYP2C9—Tamoxifen metabolism—CYP1B1—melanoma	0.000167	0.0142	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GRIN2A—melanoma	0.000155	0.0132	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—CYP17A1—melanoma	0.000144	0.0123	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—CYP17A1—melanoma	0.000142	0.0121	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—CYP1B1—melanoma	0.000121	0.0103	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—CYP1B1—melanoma	0.00012	0.0102	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GRIN2A—melanoma	0.000119	0.0101	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—UGT2B10—melanoma	0.000111	0.00944	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	9.84e-05	0.00837	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	9.37e-05	0.00798	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	9.35e-05	0.00796	CbGpPWpGaD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	8.58e-05	0.00731	CbGpPWpGaD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP17A1—melanoma	8.47e-05	0.00721	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonic acid metabolism—CYP1B1—melanoma	8.36e-05	0.00711	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—PRKCA—melanoma	8.14e-05	0.00693	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ACER3—melanoma	8.08e-05	0.00688	CbGpPWpGaD
Tolcapone—COMT—Metabolism—UGT2B10—melanoma	7.39e-05	0.00629	CbGpPWpGaD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	7.22e-05	0.00615	CbGpPWpGaD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—melanoma	7.13e-05	0.00607	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—AKR1B10—melanoma	7.05e-05	0.006	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	6.96e-05	0.00592	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HS3ST5—melanoma	6.87e-05	0.00585	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	6.52e-05	0.00555	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—PRKCA—melanoma	6.24e-05	0.00531	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—BRAF—melanoma	5.99e-05	0.0051	CbGpPWpGaD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	5.86e-05	0.00498	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PLCB4—melanoma	5.21e-05	0.00443	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—MDM2—melanoma	5.02e-05	0.00427	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIP4K2A—melanoma	4.89e-05	0.00417	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SLC6A11—melanoma	4.89e-05	0.00417	CbGpPWpGaD
Tolcapone—COMT—Metabolism—MTAP—melanoma	4.76e-05	0.00405	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ACER3—melanoma	4.66e-05	0.00396	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—BRAF—melanoma	4.59e-05	0.00391	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PHGDH—melanoma	4.24e-05	0.00361	CbGpPWpGaD
Tolcapone—COMT—Metabolism—LUM—melanoma	4.24e-05	0.00361	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HPSE—melanoma	4.16e-05	0.00354	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CUBN—melanoma	4.08e-05	0.00348	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CSPG4—melanoma	3.94e-05	0.00336	CbGpPWpGaD
Tolcapone—COMT—Metabolism—BSG—melanoma	3.94e-05	0.00336	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SDHD—melanoma	3.94e-05	0.00336	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—MDM2—melanoma	3.85e-05	0.00327	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GPAM—melanoma	3.82e-05	0.00325	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonic acid metabolism—PTGS2—melanoma	3.77e-05	0.00321	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP17A1—melanoma	3.7e-05	0.00315	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP17A1—melanoma	3.65e-05	0.0031	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—MAPK1—melanoma	3.43e-05	0.00292	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PLA2G6—melanoma	3.25e-05	0.00277	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP1B1—melanoma	3.11e-05	0.00265	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP1B1—melanoma	3.07e-05	0.00261	CbGpPWpGaD
Tolcapone—COMT—Metabolism—VCAN—melanoma	2.92e-05	0.00248	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	2.82e-05	0.0024	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—HRAS—melanoma	2.76e-05	0.00235	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—MAPK1—melanoma	2.63e-05	0.00224	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP17A1—melanoma	2.46e-05	0.0021	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CUBN—melanoma	2.35e-05	0.002	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GNA11—melanoma	2.33e-05	0.00198	CbGpPWpGaD
Tolcapone—COMT—Metabolism—FASN—melanoma	2.28e-05	0.00194	CbGpPWpGaD
Tolcapone—COMT—Metabolism—SLC5A5—melanoma	2.24e-05	0.0019	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	2.2e-05	0.00187	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CD44—melanoma	2.16e-05	0.00184	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GNAQ—melanoma	2.16e-05	0.00184	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—HRAS—melanoma	2.11e-05	0.0018	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ACER3—melanoma	2.07e-05	0.00177	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP1B1—melanoma	2.07e-05	0.00176	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—UGT2B10—melanoma	1.9e-05	0.00161	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	1.87e-05	0.00159	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HS3ST5—melanoma	1.76e-05	0.0015	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ABCB1—melanoma	1.71e-05	0.00145	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PRKCA—melanoma	1.57e-05	0.00134	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ERCC2—melanoma	1.56e-05	0.00133	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.42e-05	0.00121	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PLCB4—melanoma	1.34e-05	0.00114	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	1.31e-05	0.00112	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIP4K2A—melanoma	1.26e-05	0.00107	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC6A11—melanoma	1.26e-05	0.00107	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CG—melanoma	1.23e-05	0.00105	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—MTAP—melanoma	1.22e-05	0.00104	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.19e-05	0.00102	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PPARG—melanoma	1.19e-05	0.00101	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PHGDH—melanoma	1.09e-05	0.000927	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—LUM—melanoma	1.09e-05	0.000927	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CD—melanoma	1.08e-05	0.00092	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HPSE—melanoma	1.07e-05	0.000909	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ALB—melanoma	1.07e-05	0.000909	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CUBN—melanoma	1.05e-05	0.000893	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SDHD—melanoma	1.01e-05	0.000862	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—BSG—melanoma	1.01e-05	0.000862	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CSPG4—melanoma	1.01e-05	0.000862	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GPAM—melanoma	9.81e-06	0.000835	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CB—melanoma	9.43e-06	0.000802	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PTGS2—melanoma	9.34e-06	0.000795	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PLA2G6—melanoma	8.34e-06	0.00071	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PTEN—melanoma	8.15e-06	0.000693	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—VCAN—melanoma	7.49e-06	0.000638	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	7.09e-06	0.000604	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.84e-06	0.000583	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP17A1—melanoma	6.32e-06	0.000538	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.23e-06	0.000531	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	6.15e-06	0.000524	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GNA11—melanoma	5.97e-06	0.000508	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—FASN—melanoma	5.84e-06	0.000497	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CA—melanoma	5.75e-06	0.000489	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—SLC5A5—melanoma	5.75e-06	0.000489	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GNAQ—melanoma	5.55e-06	0.000472	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CD44—melanoma	5.55e-06	0.000472	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.43e-06	0.000462	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.38e-06	0.000458	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP1B1—melanoma	5.32e-06	0.000453	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.7e-06	0.0004	CbGpPWpGaD
Tolcapone—COMT—Metabolism—AKT1—melanoma	4.69e-06	0.0004	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ABCB1—melanoma	4.38e-06	0.000373	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PRKCA—melanoma	4.03e-06	0.000343	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ERCC2—melanoma	4e-06	0.00034	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.31e-06	0.000282	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CG—melanoma	3.16e-06	0.000269	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PPARG—melanoma	3.05e-06	0.000259	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CD—melanoma	2.78e-06	0.000236	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ALB—melanoma	2.74e-06	0.000233	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CB—melanoma	2.42e-06	0.000206	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PTGS2—melanoma	2.4e-06	0.000204	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PTEN—melanoma	2.09e-06	0.000178	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CA—melanoma	1.48e-06	0.000126	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—AKT1—melanoma	1.21e-06	0.000103	CbGpPWpGaD
